These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9925303)

  • 1. Biologically active oligodeoxyribonucleotides. Part 11: The least phosphate-modification of quadruplex-forming hexadeoxyribonucleotide TGGGAG, bearing 3-and 5-end-modification, with anti-HIV-1 activity.
    Koizumi M; Koga R; Hotoda H; Ohmine T; Furukawa H; Agatsuma T; Nishigaki T; Abe K; Kosaka T; Tsutsumi S; Sone J; Kaneko M; Kimura S; Shimada K
    Bioorg Med Chem; 1998 Dec; 6(12):2469-75. PubMed ID: 9925303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologically active oligodeoxyribonucleotides--IX. Synthesis and anti-HIV-1 activity of hexadeoxyribonucleotides, TGGGAG, bearing 3'- and 5'-end-modification.
    Koizumi M; Koga R; Hotoda H; Momota K; Ohmine T; Furukawa H; Agatsuma T; Nishigaki T; Abe K; Kosaka T; Tsutsumi S; Sone J; Kaneko M; Kimura S; Shimada K
    Bioorg Med Chem; 1997 Dec; 5(12):2235-43. PubMed ID: 9459021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologically active oligodeoxyribonucleotides. 5. 5'-End-substituted d(TGGGAG) possesses anti-human immunodeficiency virus type 1 activity by forming a G-quadruplex structure.
    Hotoda H; Koizumi M; Koga R; Kaneko M; Momota K; Ohmine T; Furukawa H; Agatsuma T; Nishigaki T; Sone J; Tsutsumi S; Kosaka T; Abe K; Kimura S; Shimada K
    J Med Chem; 1998 Sep; 41(19):3655-63. PubMed ID: 9733490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologically active oligodeoxyribonucleotides. Part 12: N2-methylation of 2'-deoxyguanosines enhances stability of parallel G-quadruplex and anti-HIV-1 activity.
    Koizumi M; Akahori K; Ohmine T; Tsutsumi S; Sone J; Kosaka T; Kaneko M; Kimura S; Shimada K
    Bioorg Med Chem Lett; 2000 Oct; 10(19):2213-6. PubMed ID: 11012032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How a modification (8-aza-3-deaza-2'-deoxyguanosine) influences the quadruplex structure of Hotoda's 6-mer TGGGAG with 5'- and 3'-end modifications.
    Jaksa S; Kralj B; Pannecouque C; Balzarini J; De Clercq E; Kobe J
    Nucleosides Nucleotides Nucleic Acids; 2004; 23(1-2):77-88. PubMed ID: 15043138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5'-Modified G-quadruplex forming oligonucleotides endowed with anti-HIV activity: synthesis and biophysical properties.
    D'Onofrio J; Petraccone L; Erra E; Martino L; Fabio GD; Napoli LD; Giancola C; Montesarchio D
    Bioconjug Chem; 2007; 18(4):1194-204. PubMed ID: 17569499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New findings on the d(TGGGAG) sequence: Surprising anti-HIV-1 activity.
    Romanucci V; Zarrelli A; Liekens S; Noppen S; Pannecouque C; Di Fabio G
    Eur J Med Chem; 2018 Feb; 145():425-430. PubMed ID: 29335208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, biophysical characterization, and anti-HIV activity of glyco-conjugated G-quadruplex-forming oligonucleotides.
    D'Onofrio J; Petraccone L; Martino L; Di Fabio G; Iadonisi A; Balzarini J; Giancola C; Montesarchio D
    Bioconjug Chem; 2008 Mar; 19(3):607-16. PubMed ID: 18254584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and anti-HIV activity of phosphorothioate antisense DNA containing C-5 polyamine substituted 2'-deoxyuridine and/or acridine residues.
    Shinozuka K; Okamoto T; Matsukura M; Sawai H
    Nucleic Acids Symp Ser; 1997; (37):215-6. PubMed ID: 9586076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologically active oligodeoxyribonucleotides. 10: anti-HIV-1 activity and stability of modified hexanucleotides containing glycerol-skeleton.
    Hotoda H; Koizumi M; Ohmine T; Furukawa H; Nishigaki T; Abe K; Kosaka T; Tsutsumi S; Sone J; Kaneko M
    Nucleosides Nucleotides; 1998; 17(1-3):243-52. PubMed ID: 9708349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties of quadruplex oligonucleotides with anti-HIV-1 activity.
    Tamura Y; Yoshida M; Suzuki J; Hiratou T; Miyano-Kurosaki N; Takai K; Takaku H
    Nucleic Acids Symp Ser; 2000; (44):181-2. PubMed ID: 12903328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polydeoxyguanine motifs in a 12-mer phosphorothioate oligodeoxynucleotide augment binding to the v3 loop of HIV-1 gp120 and potency of HIV-1 inhibition independency of G-tetrad formation.
    Lederman S; Sullivan G; Benimetskaya L; Lowy I; Land K; Khaled Z; Cleary AM; Yakubov L; Stein CA
    Antisense Nucleic Acid Drug Dev; 1996; 6(4):281-9. PubMed ID: 9012864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a phosphodiester hexanucleotide that inhibits HIV-1 infection in vitro on covalent linkage of its 5'-end with a dimethoxytrityl residue.
    Furukawa H; Momota K; Agatsuma T; Yamamoto I; Kimura S; Shimada K
    Antisense Nucleic Acid Drug Dev; 1997 Jun; 7(3):167-75. PubMed ID: 9212907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, biophysical characterization and anti-HIV activity of d(TG3AG) Quadruplexes bearing hydrophobic tails at the 5'-end.
    Romanucci V; Milardi D; Campagna T; Gaglione M; Messere A; D'Urso A; Crisafi E; La Rosa C; Zarrelli A; Balzarini J; Di Fabio G
    Bioorg Med Chem; 2014 Feb; 22(3):960-6. PubMed ID: 24433967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-HIV activity of new higher order G-quadruplex aptamers obtained from tetra-end-linked oligonucleotides.
    Nici F; Oliviero G; Falanga AP; D'Errico S; Marzano M; Musumeci D; Montesarchio D; Noppen S; Pannecouque C; Piccialli G; Borbone N
    Org Biomol Chem; 2018 Mar; 16(13):2349-2355. PubMed ID: 29543291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A versatile synthetic approach for the development of libraries of 5', 3'-bis-conjugated oligonucleotides.
    Di Fabio G; Coppola C; D'Onofrio J; De Napoli L; Montesarchio D
    Nucleic Acids Symp Ser (Oxf); 2008; (52):299-300. PubMed ID: 18776372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human immunodeficiency virus type 1 replication by P-stereodefined oligo(nucleoside phosphorothioate)s in a long-term infection model.
    Inagawa T; Nakashima H; Karwowski B; Guga P; Stec WJ; Takeuchi H; Takaku H
    FEBS Lett; 2002 Sep; 528(1-3):48-52. PubMed ID: 12297278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorothioate analogues of oligodeoxyribonucleotide: synthesis and activity as inhibitors of replication of human immunodeficiency virus.
    Kim SG; Suzuki Y; Nakashima H; Yamamoto N; Takaku H
    Biochem Biophys Res Commun; 1991 Sep; 179(3):1614-9. PubMed ID: 1930201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biophysical and biological properties of quadruplex oligodeoxyribonucleotides.
    Dapić V; Abdomerović V; Marrington R; Peberdy J; Rodger A; Trent JO; Bates PJ
    Nucleic Acids Res; 2003 Apr; 31(8):2097-107. PubMed ID: 12682360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of G-quartet-mediated tetramer formation.
    Wyatt JR; Davis PW; Freier SM
    Biochemistry; 1996 Jun; 35(24):8002-8. PubMed ID: 8672504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.